These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 22207410)

  • 1. Correlation of LAPTM4B polymorphisms with hepatocellular carcinoma in Chinese patients.
    Zhai G; Yang H; Ji X; Xiong F; Su J; McNutt MA; Li X
    Med Oncol; 2012 Dec; 29(4):2744-9. PubMed ID: 22207410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of LAPTM4B polymorphisms with gallbladder carcinoma susceptibility in Chinese patients.
    Yang H; Zhai G; Ji X; Xiong F; Su J; McNutt MA
    Med Oncol; 2012 Dec; 29(4):2809-13. PubMed ID: 22302286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between LAPTM4B gene polymorphism and susceptibility of gastric cancer.
    Liu Y; Zhang QY; Qian N; Zhou RL
    Ann Oncol; 2007 Feb; 18(2):311-6. PubMed ID: 17074969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between LAPTM4B gene polymorphism and susceptibility of primary liver cancer.
    Wang S; Zhang QY; Zhou RL
    Ann Oncol; 2012 Jul; 23(7):1864-9. PubMed ID: 22156622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LAPTM4B allele *2 is a marker of poor prognosis following hepatic tumor resection for hepatocellular carcinoma.
    Yang H; Zhai G; Ji X; Xiong F; Su J; McNutt MA
    PLoS One; 2012; 7(4):e34984. PubMed ID: 22509374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of lysosomal protein transmembrane 4 beta gene polymorphism with pancreatic carcinoma susceptibility in the Chinese population.
    Wang B; Wang S; Liang G; Xu J; Zhou R; Zhang Q
    Tumour Biol; 2017 Jun; 39(6):1010428317705518. PubMed ID: 28618967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of LAPTM4B polymorphisms with cervical carcinoma.
    Meng F; Song H; Luo C; Yin M; Xu Y; Liu H; Zhou R; Lou G
    Cancer; 2011 Jun; 117(12):2652-8. PubMed ID: 21656743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of LAPTM4B gene polymorphism with nasopharyngeal carcinoma susceptibility in a Chinese population.
    Wang B; Xu J; Zhou R; Zhang Q
    Med Oncol; 2013 Mar; 30(1):470. PubMed ID: 23345117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relationship between LAPTM4B gene polymorphism and susceptibility of lung cancer].
    Deng LJ; Zhang QY; Liu B; Zhou RL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Jun; 37(3):302-5. PubMed ID: 15968325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular cloning and characterization of LAPTM4B, a novel gene upregulated in hepatocellular carcinoma.
    Shao GZ; Zhou RL; Zhang QY; Zhang Y; Liu JJ; Rui JA; Wei X; Ye DX
    Oncogene; 2003 Aug; 22(32):5060-9. PubMed ID: 12902989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LAPTM4B allele *2 is associated with breast cancer susceptibility and prognosis.
    Li X; Kong X; Chen X; Zhang N; Jiang L; Ma T; Yang Q
    PLoS One; 2012; 7(9):e44916. PubMed ID: 22984585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between LAPTM4B gene polymorphism and susceptibility of colorectal and esophageal cancers.
    Cheng XJ; Xu W; Zhang QY; Zhou RL
    Ann Oncol; 2008 Mar; 19(3):527-32. PubMed ID: 17965115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of LAPTM4B gene polymorphism with breast cancer susceptibility.
    Fan M; Liu Y; Zhou R; Zhang Q
    Cancer Epidemiol; 2012 Aug; 36(4):364-8. PubMed ID: 22270081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic polymorphism of interleukin-16 influences susceptibility to HBV-related hepatocellular carcinoma in a Chinese population.
    Li S; Deng Y; Chen ZP; Huang S; Liao XC; Lin LW; Li H; Peng T; Qin X; Zhao JM
    Infect Genet Evol; 2011 Dec; 11(8):2083-8. PubMed ID: 22019522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression signature of lysosomal-associated transmembrane protein 4B in hepatitis C virus-induced hepatocellular carcinoma.
    Roy G; Roy P; Bhattacharjee A; Shahid M; Misbah M; Gupta S; Husain M
    Int J Biol Markers; 2018 Aug; 33(3):283-292. PubMed ID: 29882487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Identification and characterization of LAPTM4B encoded by a human hepatocellular carcinoma-associated novel gene].
    Liu X; Zhou R; Zhang Q; Zhang Y; Shao G; Jin Y; Zhang S; Lin M; Rui J; Ye D
    Beijing Da Xue Xue Bao Yi Xue Ban; 2003 Aug; 35(4):340-7. PubMed ID: 12947545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LAPTM4B allele *2 is a marker of poor prognosis for gallbladder carcinoma.
    Zhai G; Yan K; Ji X; Xu W; Yang J; Xiong F; Su J; McNutt MA; Yang H
    PLoS One; 2012; 7(9):e45290. PubMed ID: 22984631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of IL-2 polymorphisms and IL-2 serum levels with susceptibility to HBV-related hepatocellular carcinoma in a Chinese Zhuang population.
    Peng Q; Li H; Lao X; Deng Y; Chen Z; Qin X; Li S
    Infect Genet Evol; 2014 Oct; 27():375-81. PubMed ID: 25173083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LAPTM4B polymorphism increases susceptibility to multiple cancers in Chinese populations: a meta-analysis.
    Mo C; Lu Y; Deng Y; Wang J; Xie L; Li T; He Y; Peng Q; Qin X; Li S
    BMC Genet; 2014 Apr; 15():48. PubMed ID: 24746178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LAPTM4B gene polymorphism and endometrial carcinoma risk and prognosis.
    Meng F; Li H; Zhou R; Luo C; Hu Y; Lou G
    Biomarkers; 2013 Mar; 18(2):136-43. PubMed ID: 23312008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.